Octan-1-ol

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

comparable to guideline study with acceptable restrictions

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

1981

Report date:

1999

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

GLP compliance:

yes

Test type:

acute toxic class method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

Octan-1-ol

EC Number:

203-917-6

EC Name:

Octan-1-ol

Cas Number:

111-87-5

Molecular formula:

C8H18O

IUPAC Name:

octan-1-ol

Test material form:

not specified

Test animals

Species:

rat

Strain:

Wistar

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS

- Source: Winkelmann, Hanover, Germany

- Weight at study initiation: mean body weight males, 137, females 127

- Fasting period before study: fasted, time not specified

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

other: as an aqueous suspension

Details on oral exposure:

MAXIMUM DOSE VOLUME APPLIED: 25% aqueous suspension at a constant volume of 20 ml/kg.

Doses:

5 g/kg single dose level

No. of animals per sex per dose:

5M, 5F

Control animals:

not specified

Details on study design:

- Duration of observation period following administration: 14 days

- Frequency of observations and weighing:  Body weights were recorded prior to dosing and at  24 hours, 1 week and 2 weeks after dosing. 

- Necropsy of survivors performed: yes

- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: Clinical signs were observed particularly during the first 24 hours after dosing.

Results and discussion

Effect levels

Key result

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 5 000 mg/kg bw

Based on:

test mat.

Mortality:

There were no deaths during the course of the study.

Clinical signs:

other: During the first 24 hours all test animals showed some decrease in actvity and piloerection.  No adverse effects were observed during the 14 day observation period.

Gross pathology:

The were no abnormal findings.

Other findings:

No potential target organs identified, no sex xpecific differences detected.

Applicant's summary and conclusion

Interpretation of results:

GHS criteria not met

Conclusions:

The rat oral LD50 for Lorol 8 was >5g/kg when applied as an aqueous suspension. Clinical signs of intoxication were confined to slight sedation and piloerection during the first 24 hours following dosing. There was no remarkable gross pathology at necrospy and no indication of specific target organ toxicity.